My Clinical Experience with ESWL
ESWL remains a valuable tool for appropriately selected kidney stones — the complete absence of invasiveness is invaluable for certain patients. Choosing the right case is the key: ESWL is not suitable for every stone, and patients must receive realistic information about expected outcomes.
- Completely non-invasive — no incision, no anesthesia.
- Ideal for stones <1.5 cm in the upper or mid kidney with low HU density.
- Stone-free 70–90% for <1 cm after 1–3 sessions.
- Outpatient treatment — return home same day.
What Is Extracorporeal Shock Wave Lithotripsy (ESWL)?
ESWL uses high-energy focused acoustic shock waves generated outside the body, directed precisely onto the stone using imaging guidance (fluoroscopy or ultrasound). The waves pass through body tissues without causing damage and fragment the stone into small pieces that pass naturally in the urine.
External Wave Focusing
Shock waves are generated by an external device (electrohydraulic, electromagnetic, or piezoelectric) and focused on the stone under fluoroscopic or ultrasound guidance.
Fragmentation Mechanism
Waves enter and reflect at the stone surface, creating alternating tensile and compressive forces that fracture the hard calculus.
No Incision
The entire treatment is performed without any incision or instrument insertion — the patient lies comfortably on a specialized treatment table.
Indications & Stone Selection
Renal Stones <2 cm (ideally <1.5 cm)
Ideal indication. Upper or mid-pole stones with soft composition (<1000 HU). Lower calyx stones: reduced efficacy due to anatomical drainage difficulty.
Upper Ureter Stones <1 cm
ESWL is effective for proximal ureteral stones. For mid and distal ureter: ureteroscopic laser lithotripsy (URS) is superior.
Uric Acid Stones
Radiolucent uric acid stones (low density) respond well to ESWL. Alternatively, uric acid stones may be dissolved non-invasively with urinary alkalinization (chemolysis).
Absolute Contraindications: Pregnancy, uncontrolled coagulation disorder, aortic or renal artery aneurysm near the stone. Pacemaker: relative contraindication — cardiology evaluation required.
Preoperative Assessment
Low-Dose CT (Urolithiasis Protocol)
Mapping of stone size, location, and density (Hounsfield units). Stones >1000–1200 HU: reduced ESWL efficacy.
Urine Culture
Exclude active infection. Treat if positive before ESWL.
Anticoagulant Review
Warfarin/NOAC must be discontinued before ESWL to reduce perinephric hematoma risk.
How ESWL Works
Positioning & Focusing
Patient positioned on the ESWL treatment table. Stone located with fluoroscopy or ultrasound. Shock waves focused precisely on the stone.
Shock Wave Delivery
2,000–4,000 shock waves at variable energy settings. Session duration 30–60 minutes. Mild analgesia or IV sedation for comfort.
Fragmentation & Monitoring
Fluoroscopic re-check during session to verify adequate fragmentation. Refocusing applied if needed.
Return Home
Outpatient procedure — patient returns home the same or following day. Hydration >2 L/day for fragment passage.
Duration & Sessions
After ESWL & Follow-up
First 2–4 Weeks
Fragment passage in urine: mild hematuria and some renal colic during passage are expected and normal. Hydration >2 L/day.
Efficacy Assessment
Ultrasound or low-dose CT 4–6 weeks after session to evaluate stone-free status or need for repeat treatment.
Metabolic Evaluation
After stone clearance: stone composition analysis + 24-hour urine collection. Dietary guidance and pharmacological recurrence prevention.
ESWL vs PCNL & RIRS
ESWL: Unique Advantage
The only completely non-invasive stone treatment. No anesthesia, no incision, outpatient. Ideal for patients with high anesthetic risk or those who prefer to avoid surgery.
ESWL vs PCNL (for >2 cm)
PCNL stone-free 85–95% vs ESWL <50%. For stones >2 cm: ESWL is inadequate — PCNL is first-line.
ESWL vs RIRS (for 1–2 cm)
For stones 1–2 cm: RIRS stone-free ~85–90% vs ESWL 50–70%. RIRS is superior but invasive. Choice depends on stone hardness, anatomy, and patient preference.
Possible Complications
Steinstrasse (2–10%)
Most commonAccumulation of stone fragments in the ureter causing obstruction. Higher risk with stones >1.5 cm. Managed with DJ stent or URS laser lithotripsy.
Perinephric Hematoma (<1%)
RareBleeding around the kidney. Treated conservatively. Higher risk with anticoagulation or uncontrolled hypertension.
Pain During Fragment Passage
ExpectedRenal colic as fragments travel down the ureter. Managed with NSAIDs and alpha-blockers (tamsulosin) to facilitate passage.
Infection (<1%)
RareRisk in struvite stones or active UTI. Prevention: urine culture before ESWL + antibiotic prophylaxis.
Frequently Asked Questions
What is extracorporeal shock wave lithotripsy (ESWL)?
ESWL (Extracorporeal Shockwave Lithotripsy) is the non-invasive treatment of kidney stones using externally generated acoustic shock waves. The waves are focused on the stone without any incision and fragment it into small pieces that pass naturally in the urine. No anesthesia is required — performed entirely from outside the body.
What stone size is suitable for ESWL?
EAU 2024: ESWL is indicated for stones <2 cm (ideally <1.5 cm) in the kidney or upper ureter. Best results: stones in the upper or mid kidney, low density (<1000 HU on CT). For stones >2 cm: PCNL is superior.
How many ESWL sessions are typically needed?
For stones <1 cm: 1–2 sessions. For stones 1–2 cm: 2–3 sessions. Each session delivers 2,000–4,000 shock waves. Sessions are repeated every 2–4 weeks to allow fragment passage. If adequate results are not achieved after 3 sessions, treatment strategy should be re-evaluated (RIRS or PCNL).
Is anesthesia required for ESWL?
Typically not — ESWL is performed without anesthesia, with mild intravenous sedation or analgesia for patient comfort. In children and particularly sensitive patients, general anesthesia may be administered.
What are the contraindications for ESWL?
Absolute: pregnancy, uncontrolled bleeding disorder, aortic or renal artery aneurysm near the stone. Pacemaker: relative contraindication — cardiology assessment required. Relative: BMI >35 (difficult wave focusing), anatomical anomaly impairing fragment passage, stone density >1200 HU (inadequate fragmentation).
What are the stone-free rates for ESWL?
Depends on stone size, location, and density. Generally: stones <1 cm: stone-free 70–90% after 1–3 sessions. Stones 1–2 cm: 50–70%. Stones >2 cm: <50% — which is why PCNL or RIRS are preferred for >2 cm.
What is Steinstrasse and how is it managed?
Steinstrasse (German: "stone street") is the accumulation of stone fragments in the ureter after ESWL, causing obstruction. More common after fragmenting larger stones. Managed with ureteroscopic laser lithotripsy, DJ stent, or PCNL in severe cases.
Can ESWL be performed in a patient on anticoagulant therapy?
Anticoagulants (Warfarin, NOACs) must be discontinued before ESWL to avoid perinephric hematoma. Low-dose aspirin: relative contraindication — discuss with your specialist. P2Y12 inhibitors: stop per institutional protocol.
Related Topics
Book an Appointment in Rhodes
Kidney stone diagnosed? Get a specialist evaluation for ESWL or alternative lithotripsy at our urology practice in Rhodes.
Bibliography & References
- EAU Guidelines on Urolithiasis 2024 — uroweb.org
- Skolarikos A, et al. Extracorporeal Shockwave Lithotripsy 25 Years Later: Complications and Their Prevention. Eur Urol 2006;50:981–990.
- Preminger GM, et al. AUA Guideline on Management of Staghorn Calculi. J Urol 2005;173:1991–2000.
- Turk C, et al. EAU Guidelines on Urolithiasis. Eur Urol 2016;69:475–482.
Medical Review
Dr. Marinos Vasilas, Urologist – Andrologist
Dr. Marinos Vasilas evaluates every kidney stone case and recommends the most appropriate treatment — ESWL, RIRS, or PCNL — based on stone size, density, anatomy, and clinical status.
Full Profile
